Watchlist Price Alert

Sunshine Biopharma Inc. (SBFM)

NASDAQ: SBFM · Real-Time Price · USD

1.47

-0.03 (-2.00%)

At close: May 19, 2025, 10:49 AM

Sunshine Biopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	34.87M	24.09M	4.35M	228.43K	71.41K	21.12K	447.2K	n/a	n/a
Cost of Revenue	24.2M	15.75M	2.65M	117.83K	25.85K	11.05K	391.08K	6.63K	60.73K
Gross Profit	10.67M	8.34M	1.7M	110.6K	45.56K	10.07K	56.12K	-6.63K	-60.73K
Operating Income	-5.81M	-4.79M	-8.67M	-2.44M	-576.87K	-641.64K	-1.17M	-857.19K	-993.11K
Interest Income	496K	811.97K	518.65K	328.82K	168.1K	115.9K	n/a	n/a	n/a
Pretax Income	-5.37M	-4.11M	-26.51M	-12.44M	-2.78M	-1.08M	-2.16M	-1.04M	-3.5M
Net Income	-5.13M	-4.51M	-26.74M	-12.77M	-897.68K	-1.46M	-2.16M	-1.04M	-3.5M
Selling & General & Admin	14.94M	10.83M	9.48M	1.87M	547.42K	622.73K	1.21M	850.56K	899.58K
Research & Development	n/a	1.86M	811.86K	672.21K	60.95K	15.2K	12.8K	n/a	32.79K
Other Expenses	n/a	438.88K	80.4K	12.74K	14.07K	13.77K	-871.73K	-76.93K	60.73K
Operating Expenses	16.48M	13.12M	10.37M	2.55M	622.44K	651.71K	1.22M	857.19K	993.11K
Interest Expense	8.77K	137.31K	39.41K	328.82K	168.1K	115.9K	159.42K	104.83K	34.73K
Selling & Marketing Expenses	940.28K	734.25K	578.09K	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	41.63M	28.88M	13.02M	2.67M	648.28K	662.76K	1.61M	857.19K	993.11K
Income Tax Expense	-234.86K	395.17K	233.3K	328.82K	-1.89M	383.39K	-41.53K	1.29K	2.47M
Shares Outstanding (Basic)	701.75K	12.16K	7.59K	1.31K	866.00	1.76K	15.23K	43.63K	21.24K
Shares Outstanding (Diluted)	701.75K	12.16K	7.59K	1.31K	866.00	1.76K	15.23K	43.63K	21.24K
EPS (Basic)	-7.32	-370.41	-3.52K	-9.77K	-1.04K	-828.01	-141.54	-23.84	-164.63
EPS (Diluted)	-7.32	-370.41	-3.52K	-9.77K	-1.04K	-828.01	-141.54	-23.84	-164.63
EBITDA	-5.15M	-3.82M	-26.45M	-12.09M	-2.6M	-948.38K	-1.95M	-928.78K	-932.38K
EBIT	-5.38M	-3.97M	-26.47M	-12.11M	-2.62M	-962.15K	-1.99M	-935.41K	-993.11K
Depreciation & Amortization	223.53K	149.15K	25.16K	12.74K	14.07K	13.77K	49.36K	6.63K	60.73K